We use cookies to improve your experience. By continuing to browse this site, you accept our cookie policy.×
Skip main navigation
Aging Health
Bioelectronics in Medicine
Biomarkers in Medicine
Breast Cancer Management
CNS Oncology
Colorectal Cancer
Concussion
Epigenomics
Future Cardiology
Future Medicine AI
Future Microbiology
Future Neurology
Future Oncology
Future Rare Diseases
Future Virology
Hepatic Oncology
HIV Therapy
Immunotherapy
International Journal of Endocrine Oncology
International Journal of Hematologic Oncology
Journal of 3D Printing in Medicine
Lung Cancer Management
Melanoma Management
Nanomedicine
Neurodegenerative Disease Management
Pain Management
Pediatric Health
Personalized Medicine
Pharmacogenomics
Regenerative Medicine

An observational study on the clinical features of esophageal cancer followed by multiple primary cancers

    Zhipeng Hu

    Department of Cardiovascular Surgery, Renmin hospital of Wuhan University, 238 Jiefang Road, Wuhan City of Hubei Provice, PR China

    ,
    Min Zhang

    Department of Cardiovascular Surgery, Renmin hospital of Wuhan University, 238 Jiefang Road, Wuhan City of Hubei Provice, PR China

    ,
    Zhiwei Wang

    *Author for correspondence:

    E-mail Address: wangzhiwei@whu.edu.cn

    Department of Cardiovascular Surgery, Renmin hospital of Wuhan University, 238 Jiefang Road, Wuhan City of Hubei Provice, PR China

    ,
    Junlong Song

    Department of Breast & Thyroid Surgery, Renmin hospital of Wuhan University, 238 Jiefang Road, Wuhan City of Hubei Provice, PR China

    ,
    Wanli Jiang

    Department of Cardiovascular Surgery, Renmin hospital of Wuhan University, 238 Jiefang Road, Wuhan City of Hubei Provice, PR China

    ,
    Luocheng Li

    Department of Cardiovascular Surgery, Renmin hospital of Wuhan University, 238 Jiefang Road, Wuhan City of Hubei Provice, PR China

    &
    Xiaoping Hu

    Department of Cardiovascular Surgery, Renmin hospital of Wuhan University, 238 Jiefang Road, Wuhan City of Hubei Provice, PR China

    Published Online:https://doi.org/10.2217/fon-2018-0621

    Aim: To investigate the nature of multiple primary cancers initiated by esophageal cancer-multiple primary cancers (EC-MPC). Patients & methods: SEER data about patients’/tumor characteristics, and survival were analyzed and compared. Results & conclusion: 1727 of 29,733 registered EC patients have EC-MPC. Individuals diagnosed at 60–79 years old, earlier stage and/or moderately differentiated EC were more likely to get EC-MPC. Fewer patients in the EC-MPC group suffered from metastases. Patients in the EC-MPC group showed a longer survival rate and lower EC-specific deaths. Other factors like age, sex, race, tumor differentiation and Tumor, Node, Metastasis stage also affected survival. Radiation can improve survival. EC-MPC patients have some distinct features compared with solitary EC.

    Papers of special note have been highlighted as: • of interest; •• of considerable interest

    References

    • 1 Jena A, Patnayak R, Lakshmi AY, Manilal B, Reddy MK. Multiple primary cancers: an enigma. South Asian J. Cancer 5(1), 29–32 (2016).
    • 2 Noguchi T, Kato T, Takeno S, Wada S, Yanagisawa S, Suzuki M. Necessity of screening for multiple primary cancers in patients with esophageal cancer. Ann. Thorac. Cardiovasc. Surg. 8(6), 336–342 (2002). •• Figures out the importance of ruling out multiple primary cancers in patients with esophageal cancer.
    • 3 Kumagai Y, Kawano T, Nakajima Y et al. Multiple primary cancers associated with esophageal carcinoma. Surg. Today 31(10), 872–876 (2001).
    • 4 Natsugoe S, Matsumoto M, Okumura H et al. Multiple primary carcinomas with esophageal squamous cell cancer: clinicopathologic outcome. World J. Surg. 29(1), 46–49 (2005).
    • 5 Lee GD, Kim YH, Kim JB et al. Esophageal cancer associated with multiple primary cancers: surgical approaches and long-term survival. Ann. Surg. Oncol. 20(13), 4260–4266 (2013). • Although a small number of patients included, this study investigated the survival of esophageal cancer-multiple primary cancer using their own data.
    • 6 Makuuchi H, Tanaka H, Shimada H et al. Esophageal cancer and multiple primary cancer. Gan To Kagaku Ryoho 24(1), 1–7 (1997).
    • 7 Moreno-Villanueva M, Wong M, Lu T, Zhang Y, Wu H. Interplay of space radiation and microgravity in DNA damage and DNA damage response. NPJ Microgravity 3, 14 (2017).
    • 8 Geist DC, Grotzinger PJ, Bothe FA. Multiple primary cancer. Am. Pract. Dig. Treat. 1(11), 1169–1171 (1950).
    • 9 Fjermeros H. Multiple primary cancer. Tidsskr Nor Laegeforen. 76(8), 252–253; passim (1956).
    • 10 Baba Y, Yoshida N, Kinoshita K et al. Clinical and prognostic features of patients with esophageal cancer and multiple primary cancers: a retrospective single-institution study. Ann. Surg. 267(3), 478–483 (2018). • Although a small number of patients included, investigates the survival of esophageal cancer-multiple primary cancer using their own data.
    • 11 Gursel B, Meydan D, Ozbek N, Ozdemir O, Odabas E. Multiple primary malignant neoplasms from the black sea region of Turkey. J. Int. Med. Res. 39(2), 667–674 (2011).
    • 12 Evans HS, Lewis CM, Robinson D, Bell CM, Moller H, Hodgson SV. Incidence of multiple primary cancers in a cohort of women diagnosed with breast cancer in southeast England. Br. J. Cancer 84(3), 435–440 (2001).
    • 13 Enzinger PC, Mayer RJ. Esophageal cancer. N. Engl. J. Med. 349(23), 2241–2252 (2003).
    • 14 Brown LM, Devesa SS. Epidemiologic trends in esophageal and gastric cancer in the United States. Surg. Oncol. Clin. N. Am. 11(2), 235–256 (2002).
    • 15 Zhou Z, Xia Y, Bandla S et al. Vitamin D receptor is highly expressed in precancerous lesions and esophageal adenocarcinoma with significant sex difference. Hum. Pathol. 45(8), 1744–1751 (2014).
    • 16 Hong Y, Chen W, Du X et al. Upregulation of sex-determining region Y-box 9 (SOX9) promotes cell proliferation and tumorigenicity in esophageal squamous cell carcinoma. Oncotarget 6(31), 31241–31254 (2015).
    • 17 Miao Y, Liu R, Pu Y, Yin L. Trends in esophageal and esophagogastric junction cancer research from 2007 to 2016: a bibliometric analysis. Medicine (Baltimore) 96(20), e6924 (2017).
    • 18 Jain S, Dhingra S. Pathology of esophageal cancer and Barrett's esophagus. Ann. Cardiothorac. Surg. 6(2), 99–109 (2017).
    • 19 Migliore M, Rassl D, Criscione A. Longitudinal and circumferential resection margin in adenocarcinoma of distal esophagus and cardia. Future Oncol. 10(5), 891–901 (2014).
    • 20 Pusung M, Zeki S, Fitzgerald R. Genomics of esophageal cancer and biomarkers for early detection. Adv. Exp. Med. Biol. 908, 237–263 (2016).
    • 21 Liu R, Liao J, Yang M et al. Circulating miR-155 expression in plasma: a potential biomarker for early diagnosis of esophageal cancer in humans. J. Toxicol. Environ. Health A 75(18), 1154–1162 (2012).
    • 22 Lynch HT, Harris RE, Lynch PM, Guirgis HA, Lynch JF, Bardawil WA. Role of heredity in multiple primary cancer. Cancer 40(4 Suppl.), 1849–1854 (1977).
    • 23 Cybulski C, Nazarali S, Narod SA. Multiple primary cancers as a guide to heritability. Int. J. Cancer 135(8), 1756–1763 (2014).
    • 24 Morita M, Saeki H, Ito S et al. Surgical strategies for esophageal cancer associated with head and neck cancer. Surg. Today 44(9), 1603–1610 (2014).
    • 25 Nandy N, Dasanu CA. Incidence of second primary malignancies in patients with esophageal cancer: a comprehensive review. Curr. Med. Res. Opin. 29(9), 1055–1065 (2013).
    • 26 Veldeman L, Madani I, Hulstaert F, De Meerleer G, Mareel M, De Neve W. Evidence behind use of intensity-modulated radiotherapy: a systematic review of comparative clinical studies. Lancet Oncol. 9(4), 367–375 (2008).
    • 27 Ng J, Lee P. The role of radiotherapy in localized esophageal and gastric cancer. Hematol. Oncol. Clin. North Am. 31(3), 453–468 (2017).
    • 28 Schreiber D, Rineer J, Vongtama D et al. Impact of postoperative radiation after esophagectomy for esophageal cancer. J. Thorac. Oncol. 5(2), 244–250 (2010).
    • 29 Shridhar R, Almhanna K, Meredith KL et al. Radiation therapy and esophageal cancer. Cancer Control 20(2), 97–110 (2013).
    • 30 Farrelly J, McEntee MC. Principles and applications of radiation therapy. Clin. Tech. Small Anim. Pract. 18(2), 82–87 (2003).